TABLE 2.
No cardiovascular disease | 10–16% | |
Congenital heart disease | Pulmonary valve stenosis | 25–71% |
Atrial septal defect | 4–57% | |
Ventricular septal defect | 1–14% | |
Atrioventricular canal defect | 1–13% | |
Mitral abnormalities | 2–17% | |
Aortic coarctation | 2–9% | |
Patent ductus arteriosus | 1–6% | |
Tetralogy of Fallot | 1–4% | |
Other cardiovascular | Hypertrophic cardiomyopathy | 10–29% |
Arterial aneurysms | <1% |
Data obtained from 12 cohorts of patients with a clinically established NS diagnosis, with n ≥ 20: (Burch et al., 1993; Ishizawa, Oho, Dodo, Katori, & Homma, 1996; Marino, Digilio, Toscano, Giannotti, & Dallapiccola, 1999; Bertola et al., 2000; Tartaglia et al., 2002; Sarkozy et al., 2003; Shaw, Kalidas, Crosby, Jeffery, & Patton, 2007; Sznajer et al., 2007; Smpokou, Tworog-Dube, Kucherlapati, & Roberts, 2012; Colquitt & Noonan, 2014; Li, X et al., 2019).